Citigroup’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Citigroup’s Portfolio ASPX Stock Details ASPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-13,231	Closed	-$1.33M	–	8093
2015 Q1	$1.33M	Buy	13,231 +4,166	+46%	+$278K	﹤0.01%	2845
2014 Q4	$476K	Buy	9,065 +6,953	+329%	+$204K	﹤0.01%	3935
2014 Q3	$54K	Buy	2,112 +315	+18%	+$6.7K	﹤0.01%	5269
2014 Q2	$41K	Buy	1,797 +351	+24%	+$7.68K	﹤0.01%	5303
2014 Q1	$44K	Buy	+1,446	New	+$38.9K	﹤0.01%	5574

Citigroup's ASPX Position: Q2 2015 in Review

Citigroup sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 13,231 shares — an estimated $1.33M sold.

Citigroup first reported a position in ASPX in Q1 2014 and held it in 5 quarters. The position peaked at $1.33M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

Citigroup reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Citigroup sold 13,231 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $1.33M.
Citigroup first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 5 quarters.
Citigroup's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $1.33M in Q1 2015.
0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Citigroup's 13F filing for Q2 2015, filed 13 Aug 2015.